Well, let's put it this way, TGTX' drug combo is supposed to be better and safer than that of PCYC. Abbvie paid some $26 Billion for PCYC. There is no way TGTX is not being watched by other major drug companies as a takeover target. I would think a takeover would be sooner than later because once this combo is approved, the price tag soars....
I've never seen insider sales like this. Most of them sold the majority of their holdings in the last few weeks! That certainly isn't a good sign or am I missing something?
IOT chips are one of the hottest sectors going. If this company has a chip this good, things are about to change dramatically. Just look at it this way, one of the biggest car sensor companies already signed a deal with QUIK? That speaks volumes. This company may have finally found it's Golden Goose...
Very impressive company web site and this company is in Silicon Valley, so this is the real deal. If this chip is as good as advertised on their web site and uses low power, there's billions of devices this is capable of going into. That's a very impressive first partner they signed.
sorry, they just diluted in May.....come back next year and maybe your timing will be better about dilution. They aren't diluting two months after just having diluted. You can't possibly be that naïve.
That's the problem with shorting CRR. Expectations are so low that they can announce a bad Q and fly higher.
good point. the longs are happy to pay him a huge bonus, I guess for the fruit or whatever he puts out at the shareholder's meeting. I can't imagine why else they'd be happy with his big bonus
You are absolutely right I never thought about that. MSFT paid for this junk and they don't even want to use it. That is eye opening for sure
Looks like they hit the panic button. MSFT was their last hope to make it as a company. When the company that paid a settlement won't even use you in their products, you know you're finished. The IV board clearly pointed out that MSFT is using a company called StrongVPN. That leaves VHC out in the cold unless they get some SDNI business, but it doesn't appear the great KL has gotten that off the ground yet, just like everything else he promises sits idle.
Thanks for clearing that up pharma. That makes TGTX even more of a great investment and certainly that much more attractive as a partner or buyout candidate.
Sorry golder, but I think you meant to say deep into Phase 2 trials. If this had a big phase 3 drug, this would be on everyone's radar.
This is getting real interesting now.